Creative Medical Technology Holdings, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K |
| Cost of Revenue | $2.2K | $4.4K | $3.6K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K |
| Gross Profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K |
| Gross Margin | 63.4% | 60.0% | 60.0% | 67.8% | 45.4% | 69.2% | 72.5% | 43.4% |
| Operating Expenses | ||||||||
| Research & Development | $2.3M | $2.4M | $2.0M | $6.3M | $109.2K | $0 | $0 | $96.6K |
| SG&A Expense | $3.8M | $3.2M | $3.6M | $3.9M | $3.0M | $1.2M | $1.2M | $1.1M |
| Operating Income | $-6.1M | $-5.7M | $-5.6M | $-10.2M | $-3.1M | $-1.1M | $-1.1M | $-1.1M |
| Operating Margin | -102,380.2% | -52,216.9% | -62,445.9% | -11,562.5% | -3,562.2% | -677.7% | -682.9% | -895.7% |
| Interest Expense | — | — | — | $0 | $4.3M | $1.2M | $1.9M | $1.4M |
| Pretax Income | $-6.0M | $-5.5M | $-5.3M | $-10.1M | $19.2M | $-36.3M | $-8.5M | $-13.7M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-6.0M | $-5.5M | $-5.3M | $-10.1M | $19.2M | $-36.3M | $-8.5M | $-13.7M |
| Net Margin | -99,916.8% | -49,940.7% | -58,739.7% | -11,449.3% | 21,892.8% | -22,082.2% | -5,126.1% | -10,977.2% |
| EPS (Basic) | — | — | — | $-0.93 | $2.46 | $-3.48 | $-0.05 | $-0.19 |
| EPS (Diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $1.87 | $-3.48 | $-0.05 | $-0.19 |
| Shares Outstanding (Basic) | — | — | — | 10.9M | 7.8M | 10.4M | 404.8M | 16.25B |
| Shares Outstanding (Diluted) | 2.4M | 1.5M | 1.4M | 10.9M | 9.7M | 10.4M | 404.8M | 16.25B |
| Dividends Per Share | — | — | — | — | — | — | — | — |